Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Radical Collaboration. Real-World Impact.
Texas expertise fuels the discovery and delivery of next-generation preventions, diagnoses, treatments and cures.
LET'S GO
World Class. Close to Home.
We’re working to make seamless, person-centered care the standard in Central Texas and beyond.
Get Care
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
EXPLORE
Make an Appointment Give Faculty Students Alumni Directory

Aaron Brock Roller, M.D.

Education

M.D. with distinction in Research
University of Rochester School of Medicine

Residency/Fellowship

Internship, Preliminary Medicine
OhioHealth Riverside Methodist Hospital

Residency
University of Iowa Hospitals and Clinics

Fellowship in Vitreoretinal Disease and Surgery
University of Iowa Hospitals and Clinics

About

Aaron Brock Roller, M.D., is a board-certified and fellowship-trained vitreoretinal surgeon who has practiced in Austin since 2012. He is honored to be part of the amazing team of physicians and residents within the Department of Opthamology at Dell Medical School.

Dr. Roller completed an undergraduate degree in molecular biology at the University of California, Santa Cruz. He earned his medical degree from the University of Rochester School of Medicine. During his medical studies, he was awarded the Research to Prevent Blindness Medical Student Eye Research Fellowship award, with which he spent a year at UCLA designing and testing gene therapy platforms in animal models of human inherited retinal diseases. He completed a residency in opthalmology from the University of Iowa and remained at Iowa for an intensive two-year fellowship in vitreoretinal disease and surgery.

Dr. Roller’s clinical practice entails management of diabetic eye disease, macular degeneration, retinal detachment, ocular trauma and ocular inflammatory conditions. He has a special interest in inherited retinal disease and is a clinical investigator in numerous clinical research trials here in Austin.